The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis

Background and objectives: Everolimus (EVE) is a mammalian target of the rapamycin (mTOR) inhibitor that is widely used in cancer patients. Pulmonary toxicity, usually manifesting as interstitial pneumonitis, is a serious adverse effect of this drug. Radiation therapy, which is often administered in...

Descripción completa

Detalles Bibliográficos
Autores principales: Eren, Mehmet Fuat, Ay Eren, Ayfer, Sayan, Mutlay, Yücel, Birsen, Elagöz, Şahende, Özgüven, Yıldıray, Vergalasova, Irina, Altun, Ahmet, Kılıçkap, Saadettin, Daliparty, Vasudev Malik, Beşe, Nuran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404687/
https://www.ncbi.nlm.nih.gov/pubmed/32668776
http://dx.doi.org/10.3390/medicina56070348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404687/
https://www.ncbi.nlm.nih.gov/pubmed/32668776
http://dx.doi.org/10.3390/medicina56070348

Ejemplares similares